D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 141,300
-12,800 (-8.31%)
Jul 21, 2025, 10:19 AM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 1.67 trillion as of July 18, 2025. Its market cap has increased by 471.86% in one year.
Market Cap
1.67T
Enterprise Value
1.65T
Revenue
10.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
141,300.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 1.67T, an increase of 339.32%. That is a compound annual growth rate of 239.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 1,667.47B | 224.66% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.80T |
| Celltrion | 39.82T |
| ALTEOGEN | 26.19T |
| Yuhan | 9,866.54B |
| SK Biopharmaceuticals | 8,066.26B |
| HLB Co., Ltd. | 6,939.04B |
| Peptron | 6,861.07B |
| PharmaResearch | 5,890.93B |